chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pregnancy test, Ultrasound foetal
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 31-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 028L20A) for COVID-19 vaccination.     Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 21-Aug-2020 and the estimated date of delivery was 27-May-2021. On 03-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  nineteenth week of the pregnancy.  On 03-Jan-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Sep-2020, Pregnancy test: positive (Positive) positive. On 15-Sep-2020, Ultrasound foetal: normal (normal) normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The date of positive pregnancy test was 15-Sep-2020. The patient has an established prenatal care. No treatment medications provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: Heart rate higher than it normally is; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Heart rate higher than it normally is) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Anaphylaxis.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced HEART RATE INCREASED (Heart rate higher than it normally is). On 17-Jan-2021, HEART RATE INCREASED (Heart rate higher than it normally is) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered HEART RATE INCREASED (Heart rate higher than it normally is) to be possibly related.    Treatment information not provided.
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Urticaria
Clinical narrative: sore arm; super itchy and breaking out with hives; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of INJECTION SITE PAIN (sore arm) and URTICARIA (super itchy and breaking out with hives) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021 at 6:20 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced URTICARIA (super itchy and breaking out with hives). On an unknown date, the patient experienced INJECTION SITE PAIN (sore arm). At the time of the report, INJECTION SITE PAIN (sore arm) and URTICARIA (super itchy and breaking out with hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered INJECTION SITE PAIN (sore arm) and URTICARIA (super itchy and breaking out with hives) to be possibly related.    Patient states she has not been exposed to any new food, soap, or solutions.   Treatment information not provided.
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Pain in extremity
Clinical narrative: Pain in the right arm muscle that takes whole arm; Weakness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the right arm muscle that takes whole arm) and MUSCULAR WEAKNESS (Weakness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in the right arm muscle that takes whole arm) and MUSCULAR WEAKNESS (Weakness). At the time of the report, PAIN IN EXTREMITY (Pain in the right arm muscle that takes whole arm) and MUSCULAR WEAKNESS (Weakness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient received Tylenol, Bediatil, warm and hot compress for treatment.   No concomitant medication reported.
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal chest pain, Vaccination site pain
Clinical narrative: Pain in Ribcage; Pain (Injection Site); This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL CHEST PAIN (Pain in Ribcage) and VACCINATION SITE PAIN (Pain (Injection Site)) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Hypertension in December 2015, Flutter atrial in August 2017 and Subdural hematoma removal in September 2015. Concurrent medical conditions included Drug allergy (Norco (Tetracycline, Hydrocodone, Bitartrate, Acetaminophen)) and Drug allergy (Achromycin (Tetracycline HCL)). Concomitant products included CEFALEXIN MONOHYDRATE (LEXIPRON) for Depression, LOSARTAN for Hypertension, LATANOPROST for Prevent Glaucoma, APIXABAN (ELIQUIS) for blood thinner, ATORVASTATIN CALCIUM (LIPITOR) for stroke prevention.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced MUSCULOSKELETAL CHEST PAIN (Pain in Ribcage) and VACCINATION SITE PAIN (Pain (Injection Site)). At the time of the report, MUSCULOSKELETAL CHEST PAIN (Pain in Ribcage) and VACCINATION SITE PAIN (Pain (Injection Site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.    Most recent FOLLOW-UP information incorporated above includes: On 12-Apr-2021: No specific follow-up information recorded. On 20-Apr-2021: No specific follow-up information recorded.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Lymphadenopathy, Muscle spasms
Clinical narrative: Serious arm pain; cramps; fatigue; fever spikes; chills; muscle pain; terrible Headache; neck glands swollen; nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Serious arm pain), MUSCLE SPASMS (cramps), FATIGUE (fatigue), PYREXIA (fever spikes) and CHILLS (chills) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Jan-2021 at 8:30 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (Serious arm pain), MUSCLE SPASMS (cramps), FATIGUE (fatigue), PYREXIA (fever spikes), CHILLS (chills), MYALGIA (muscle pain), HEADACHE (terrible Headache), LYMPHADENOPATHY (neck glands swollen) and NAUSEA (nausea). On 21-Jan-2021, PAIN IN EXTREMITY (Serious arm pain), MUSCLE SPASMS (cramps), FATIGUE (fatigue), PYREXIA (fever spikes), CHILLS (chills), MYALGIA (muscle pain), LYMPHADENOPATHY (neck glands swollen) and NAUSEA (nausea) outcome was unknown. At the time of the report, HEADACHE (terrible Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported.   Treatment information not provided
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pain in extremity, Pyrexia
Clinical narrative: Serious arm pain; cramps; fatigue; fever spikes; chills; muscle pain; terrible Headache; neck glands swollen; nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Serious arm pain), MUSCLE SPASMS (cramps), FATIGUE (fatigue), PYREXIA (fever spikes) and CHILLS (chills) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Jan-2021 at 8:30 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (Serious arm pain), MUSCLE SPASMS (cramps), FATIGUE (fatigue), PYREXIA (fever spikes), CHILLS (chills), MYALGIA (muscle pain), HEADACHE (terrible Headache), LYMPHADENOPATHY (neck glands swollen) and NAUSEA (nausea). On 21-Jan-2021, PAIN IN EXTREMITY (Serious arm pain), MUSCLE SPASMS (cramps), FATIGUE (fatigue), PYREXIA (fever spikes), CHILLS (chills), MYALGIA (muscle pain), LYMPHADENOPATHY (neck glands swollen) and NAUSEA (nausea) outcome was unknown. At the time of the report, HEADACHE (terrible Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported.   Treatment information not provided
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Anxiety, Feeding disorder, Feeling abnormal
Clinical narrative: Got very sick; cold not eat; loss sense of taste; legs really weak; Hard time walking; feeling misearable; situation was not fun; scared to death; Fever 103F; loss sense of smell; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of ILLNESS (Got very sick), FEEDING DISORDER (cold not eat), AGEUSIA (loss sense of taste), ANOSMIA (loss sense of smell) and RESTLESS LEGS SYNDROME (legs really weak) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LISINOPRIL and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 22-Jul-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jul-2020, the patient experienced ANOSMIA (loss sense of smell). On 25-Jul-2020, the patient experienced ILLNESS (Got very sick), FEEDING DISORDER (cold not eat), AGEUSIA (loss sense of taste), RESTLESS LEGS SYNDROME (legs really weak), GAIT DISTURBANCE (Hard time walking), FEELING ABNORMAL (feeling misearable), ANXIETY (situation was not fun; scared to death) and PYREXIA (Fever 103F). In August 2020, ILLNESS (Got very sick), FEEDING DISORDER (cold not eat), AGEUSIA (loss sense of taste), ANOSMIA (loss sense of smell), RESTLESS LEGS SYNDROME (legs really weak), GAIT DISTURBANCE (Hard time walking), FEELING ABNORMAL (feeling misearable), ANXIETY (situation was not fun; scared to death) and PYREXIA (Fever 103F) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Illness, Pyrexia, Restless legs syndrome
Clinical narrative: Got very sick; cold not eat; loss sense of taste; legs really weak; Hard time walking; feeling misearable; situation was not fun; scared to death; Fever 103F; loss sense of smell; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of ILLNESS (Got very sick), FEEDING DISORDER (cold not eat), AGEUSIA (loss sense of taste), ANOSMIA (loss sense of smell) and RESTLESS LEGS SYNDROME (legs really weak) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LISINOPRIL and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 22-Jul-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jul-2020, the patient experienced ANOSMIA (loss sense of smell). On 25-Jul-2020, the patient experienced ILLNESS (Got very sick), FEEDING DISORDER (cold not eat), AGEUSIA (loss sense of taste), RESTLESS LEGS SYNDROME (legs really weak), GAIT DISTURBANCE (Hard time walking), FEELING ABNORMAL (feeling misearable), ANXIETY (situation was not fun; scared to death) and PYREXIA (Fever 103F). In August 2020, ILLNESS (Got very sick), FEEDING DISORDER (cold not eat), AGEUSIA (loss sense of taste), ANOSMIA (loss sense of smell), RESTLESS LEGS SYNDROME (legs really weak), GAIT DISTURBANCE (Hard time walking), FEELING ABNORMAL (feeling misearable), ANXIETY (situation was not fun; scared to death) and PYREXIA (Fever 103F) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore arm). At the time of the report, VACCINATION SITE PAIN (Sore arm) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment information not provided. Patient wants to know if he can take Tylenol or ibuprofen 4 days after the shot.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Decreased appetite, Lethargy
Clinical narrative: some chills; shoulder is pretty darn painful/ if try to lift it up and do anything, it hurts; lethargic; no appetite; shoulder soreness; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (some chills), ARTHRALGIA (shoulder soreness), ARTHRALGIA (shoulder is pretty darn painful/ if try to lift it up and do anything, it hurts), LETHARGY (lethargic) and DECREASED APPETITE (no appetite) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced ARTHRALGIA (shoulder soreness). On 27-Jan-2021, the patient experienced CHILLS (some chills), ARTHRALGIA (shoulder is pretty darn painful/ if try to lift it up and do anything, it hurts), LETHARGY (lethargic) and DECREASED APPETITE (no appetite). At the time of the report, CHILLS (some chills), ARTHRALGIA (shoulder soreness), ARTHRALGIA (shoulder is pretty darn painful/ if try to lift it up and do anything, it hurts), LETHARGY (lethargic) and DECREASED APPETITE (no appetite) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.
Sex: U
Vaccine: COVID19
Symptoms: Exposure via breast milk
Clinical narrative: received vaccine, breastfeeding the whole time; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (received vaccine, breastfeeding the whole time) in a 10-week-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    MEDICAL HISTORY (Parent): Concurrent medical conditions included Maternal exposure during breast feeding.    No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced EXPOSURE VIA BREAST MILK (received vaccine, breastfeeding the whole time). At the time of the report, EXPOSURE VIA BREAST MILK (received vaccine, breastfeeding the whole time) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.  This is a case of product exposure during breastfeeding with no associated AEs. Patient will continue to be contacted for further monitoring of AEs.; Sender's Comments: This is a case of product exposure during breastfeeding with no associated AEs. Patient will continue to be contacted for further monitoring of AEs.
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Got vaccine while Pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 026L20A) for COVID-19 vaccination. No Medical History information was reported. On 05-Jan-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 11-Jun-2021. On 05-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Got vaccine while Pregnant). On 03-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Got vaccine while Pregnant) had resolved. No Concomitant medications were  reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: tested positive for COVID; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (tested positive for COVID) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 15-Jan-2021, the patient experienced COVID-19 (tested positive for COVID). At the time of the report, COVID-19 (tested positive for COVID) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: I have a little bit of a rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (I have a little bit of a rash) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Ragweed allergy and Bee sting.    On 22-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced RASH (I have a little bit of a rash). At the time of the report, RASH (I have a little bit of a rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnancy) in a 32-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 15-Jul-2020 and the estimated date of delivery was 20-Apr-2021. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-seventh week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (pregnancy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided. On 20 Aug 2020 patient was had positive pregnancy test. Patient had no previous pregnancies.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Influenza like illness, Nausea
Clinical narrative: Fever; Tiredness; Chills; Nausea; Flu like symptoms; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), CHILLS (Chills), NAUSEA (Nausea), INFLUENZA LIKE ILLNESS (Flu like symptoms) and FATIGUE (Tiredness) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A or 039L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer.    On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 03-Feb-2021, the patient experienced CHILLS (Chills), NAUSEA (Nausea) and INFLUENZA LIKE ILLNESS (Flu like symptoms). On 04-Feb-2021, the patient experienced FATIGUE (Tiredness). On 05-Feb-2021, the patient experienced PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Sore arm), CHILLS (Chills), NAUSEA (Nausea), INFLUENZA LIKE ILLNESS (Flu like symptoms), FATIGUE (Tiredness) and PYREXIA (Fever) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Body temperature: 99.9-99.3 °f 99.9-99.3 °F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient took Alvin and Benadryl for treatment.   This case was linked to MOD-2021-014794 (Linked Report).; Sender's Comments:  MOD-2021-014794:Same patient, 2nd dose of Moderna Covid-19 vaccine
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Fever; Tiredness; Chills; Nausea; Flu like symptoms; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), CHILLS (Chills), NAUSEA (Nausea), INFLUENZA LIKE ILLNESS (Flu like symptoms) and FATIGUE (Tiredness) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A or 039L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer.    On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 03-Feb-2021, the patient experienced CHILLS (Chills), NAUSEA (Nausea) and INFLUENZA LIKE ILLNESS (Flu like symptoms). On 04-Feb-2021, the patient experienced FATIGUE (Tiredness). On 05-Feb-2021, the patient experienced PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Sore arm), CHILLS (Chills), NAUSEA (Nausea), INFLUENZA LIKE ILLNESS (Flu like symptoms), FATIGUE (Tiredness) and PYREXIA (Fever) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Body temperature: 99.9-99.3 °f 99.9-99.3 °F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient took Alvin and Benadryl for treatment.   This case was linked to MOD-2021-014794 (Linked Report).; Sender's Comments:  MOD-2021-014794:Same patient, 2nd dose of Moderna Covid-19 vaccine
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Retching, Salivary hypersecretion
Clinical narrative: i got the watering juice before you vomit; dry heave; I feel queasy for a few minutes every three hours; This spontaneous case was reported by a consumer and describes the occurrence of   in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment information provided.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Eructation, Injection site pain
Clinical narrative: Very bad diarrhea; Belching with bad taste; Injection site pain to the touch; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Very bad diarrhea), ERUCTATION (Belching with bad taste) and INJECTION SITE PAIN (Injection site pain to the touch) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced DIARRHOEA (Very bad diarrhea), ERUCTATION (Belching with bad taste) and INJECTION SITE PAIN (Injection site pain to the touch). At the time of the report, DIARRHOEA (Very bad diarrhea), ERUCTATION (Belching with bad taste) and INJECTION SITE PAIN (Injection site pain to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Patient took Pepcid AC and tums as treatment.   Reporter did not allow further contact
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Pyrexia
Clinical narrative: Fever; Horrible Headache; Fatigue; Feeling dizzy; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), HEADACHE (Horrible Headache), FATIGUE (Fatigue) and DIZZINESS (Feeling dizzy) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PYREXIA (Fever), HEADACHE (Horrible Headache), FATIGUE (Fatigue) and DIZZINESS (Feeling dizzy). At the time of the report, PYREXIA (Fever), HEADACHE (Horrible Headache), FATIGUE (Fatigue) and DIZZINESS (Feeling dizzy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. T reatment information was not provided. Lab details were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: very sick; This spontaneous case was reported by a patient family member or friend and describes the occurrence of VACCINATION COMPLICATION (very sick) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 31-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced VACCINATION COMPLICATION (very sick). On 02-Feb-2021, VACCINATION COMPLICATION (very sick) had resolved.            No concomitant medications were provided. No treatment information provided.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pregnancy test, Ultrasound scan
Clinical narrative: Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnancy) in a 32-year-old female patient (gravida 3, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Latex allergy. Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) from 12-Mar-2020 to an unknown date for Anxiety.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 14-Jun-2020 and the estimated date of delivery was 20-Mar-2021. On 04-Feb-2021 at 3:30 PM, the patient experienced EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-third week of the pregnancy. The vaginal delivery occurred on 09-Mar-2021, which was reported as Full-term. For neonate 1, the birth weight was 3000 grams (6lbs 10oz) with an APGAR score of 9 and 9 at (1, 5 minutes). The outcome was reported as Term Birth w/o Complications. Fetus length is 51 with head circumference of 32.5 . On 04-Feb-2021, EXPOSURE DURING PREGNANCY (Pregnancy) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Aug-2020, Ultrasound scan: normal (normal) Nuchal scan -Normal. On 29-Oct-2020, Ultrasound scan: normal (normal) Anatomy scan -Normal. On 01-Jul-2021, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Glucose screen was performed on 12-MAR-2021 result was normal . Patient reported that her first son who was 5 years old was diagnosed as ASD .  No treatment information provided.  The patient given birth of male baby. The baby's weight was 3 kg, length was 51 cm, head circumference was 32.5 cm. APGR score was 9.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Pregnancy Outcome Form (update reporter, concomitant medications and patient details)
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Warm at injection site; Swelling at injection site; Red at injection site 4x6 inch area.; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Warm at injection site), INJECTION SITE SWELLING (Swelling at injection site) and INJECTION SITE ERYTHEMA (Red at injection site 4x6 inch area.) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol and Asthma. Concomitant products included TYROSINE for an unknown indication.    On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced INJECTION SITE WARMTH (Warm at injection site), INJECTION SITE SWELLING (Swelling at injection site) and INJECTION SITE ERYTHEMA (Red at injection site 4x6 inch area.). On 13-Jan-2021, INJECTION SITE WARMTH (Warm at injection site), INJECTION SITE SWELLING (Swelling at injection site) and INJECTION SITE ERYTHEMA (Red at injection site 4x6 inch area.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included Benadryl and Tylenol.  Patient also takes medicine for cholesterol and inhaler for asthma twice a day.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypersomnia
Clinical narrative: Slept the entire day; fatigued; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Slept the entire day) and FATIGUE (fatigued) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L02A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced HYPERSOMNIA (Slept the entire day) and FATIGUE (fatigued). At the time of the report, HYPERSOMNIA (Slept the entire day) and FATIGUE (fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications  were not reported.  The treatment medications were not  provided
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash
Clinical narrative: rash and pain on left side of her chest that went from front to back; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and RASH (rash and pain on left side of her chest that went from front to back) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included Diabetes.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 10-Jan-2021, the patient experienced RASH (rash and pain on left side of her chest that went from front to back). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown and RASH (rash and pain on left side of her chest that went from front to back) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was treated with Tylenol. No concomitant medications were provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Exposure during pregnancy, Prenatal screening test
Clinical narrative: Got vaccine and is Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Got vaccine and is Pregnant) in a female patient of an unknown age (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE (DICLEGIS) for Nausea, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was in July 2020 and the estimated date of delivery was 19-May-2021. On 22-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Got vaccine and is Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 22-Jan-2021, EXPOSURE DURING PREGNANCY (Got vaccine and is Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2020, Prenatal screening test: normal (normal) normal. In January 2021, Blood glucose: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pain
Clinical narrative: A bit tired; Headache; Arm hurt a few hours after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Arm hurt a few hours after vaccination), HEADACHE (Headache) and FATIGUE (A bit tired) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included RAMIPRIL for Blood pressure high, ATORVASTATIN, VITAMIN D3, ASCORBIC ACID, CALCIUM, MINERALS NOS, RETINOL, TOCOPHERYL ACETATE, VITAMIN B NOS, VITAMINS NOS, ZINC (CENTRUM SILVER [ASCORBIC ACID;CALCIUM;MINERALS NOS;RETINOL;TOCOPHERYL ACETATE;VITAMIN B NOS;VITAMINS NOS;ZINC]), FISH OIL and BRASSICA NAPUS, FISH OIL, GLYCINE MAX SEED, GOSSYPIUM HERBACEUM SEED, UBIDECARENONE, ZEA MAYS (OMEGA 3 & COQ10) for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced INJECTION SITE PAIN (Arm hurt a few hours after vaccination). On 16-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (Headache). On an unknown date, the patient experienced FATIGUE (A bit tired). On 16-Jan-2021, INJECTION SITE PAIN (Arm hurt a few hours after vaccination) and HEADACHE (Headache) had resolved. At the time of the report, FATIGUE (A bit tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient took Tylenol as treatment.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia, Vaccination site erythema, Vaccination site induration
Clinical narrative: high fever or 101.4; body aches; headaches; arm swollen and red at injection site; arm swollen and red at injection site; hard; inflammed; This spontaneous case was reported by a consumer and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 16-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site oedema, Vaccination site swelling
Clinical narrative: high fever or 101.4; body aches; headaches; arm swollen and red at injection site; arm swollen and red at injection site; hard; inflammed; This spontaneous case was reported by a consumer and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 16-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site urticaria, Injection site warmth
Clinical narrative: pain in arm; injection site hot to the touch; injection site has a little welt; injection site arm is swollen; injection site red; arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (pain in arm). At the time of the report, PAIN IN EXTREMITY (pain in arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jan-2021: No additional information.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: pain in arm; injection site hot to the touch; injection site has a little welt; injection site arm is swollen; injection site red; arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (pain in arm). At the time of the report, PAIN IN EXTREMITY (pain in arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jan-2021: No additional information.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. No medical history was provided by the reporter. On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced COVID-19 (COVID-19). In January 2021, the patient experienced AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell). At the time of the report, COVID-19 (COVID-19), AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided. Reporter did not allow further contact.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Throat lymph nodes are swollen and hard (both sides), it's tender to touch; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Throat lymph nodes are swollen and hard (both sides), it's tender to touch) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No concomitant medications were provided. No treatment information provided.     On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced LYMPHADENOPATHY (Throat lymph nodes are swollen and hard (both sides), it's tender to touch). At the time of the report, LYMPHADENOPATHY (Throat lymph nodes are swollen and hard (both sides), it's tender to touch) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were provided. No treatment information provided.   Reporter did not allow further contact
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Gait disturbance, Headache, Myalgia
Clinical narrative: diarrhea; severe chills, could not get warm; hurt to walk; body aches; fever; headaches; hot burning sensation at the site of injection; was in bed all day; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot burning sensation at the site of injection), DIARRHOEA (diarrhea), CHILLS (severe chills, could not get warm), GAIT DISTURBANCE (hurt to walk) and PYREXIA (fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in October 2020.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot burning sensation at the site of injection), CHILLS (severe chills, could not get warm), GAIT DISTURBANCE (hurt to walk), PYREXIA (fever) and HEADACHE (headaches). On 21-Jan-2021, the patient experienced DIARRHOEA (diarrhea). On 20-Jan-2021, VACCINATION SITE WARMTH (hot burning sensation at the site of injection) had resolved. On 21-Jan-2021, DIARRHOEA (diarrhea), GAIT DISTURBANCE (hurt to walk) and PYREXIA (fever) had resolved, CHILLS (severe chills, could not get warm) outcome was unknown. At the time of the report, HEADACHE (headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient used Tylenol as treatment.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jan-2021: No specific follow-up information recorded.